IN8BIO INC
For the period ended Dec 31, 2024. Filed Mar 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 13, 2025
INAB$0.94+1.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
(In thousands, except share and per share data)
| December 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets | ||
| Cash | $11,120 | $21,282 |
| Prepaid expenses and other current assets | 1,458 | 3,343 |
| Total Current Assets | 12,578 | 24,625 |
| Non-current assets | ||
| Property and equipment, net | 2,858 | 3,514 |
| Construction in progress | — | 182 |
| Restricted cash | 266 | 256 |
| Right-of-use assets - finance leases | 1,068 | 1,364 |
| Right-of-use assets - operating leases | 3,899 | 3,513 |
| Other non-current assets | 275 | 255 |
| Total Non-Current Assets | 8,366 | 9,084 |
| Total Assets | $20,944 | $33,709 |
| Liabilities and Stockholders' Equity | ||
| Liabilities | ||
| Current liabilities | ||
| Accounts payable | $389 | $924 |
| Accrued expenses and other current liabilities | 1,047 | 2,955 |
| Short-term finance lease liability | 694 | 694 |
| Short-term operating lease liability | 953 | 820 |
| Total Current Liabilities | 3,083 | 5,393 |
| Long-term finance lease liability | 295 | 525 |
| Long-term operating lease liability | 3,088 | 2,854 |
| Total Non-Current Liabilities | 3,383 | 3,379 |
| Total Liabilities | 6,466 | 8,772 |
| Commitments and Contingencies | ||
| Stockholders' Equity | ||
| Preferred stock, par value $0.0001 per share; 10,000,000 shares authorized at December 31, 2024 and 2023. No shares issued and outstanding | — | — |
| Common stock, par value $0.0001 per share; 490,000,000 shares authorized at December 31, 2024 and 2023; 72,483,253 and 43,287,325 shares issued and outstanding at December 31, 2024 and 2023, respectively | 7 | 4 |
| Additional paid-in capital | 136,127 | 116,152 |
| Accumulated deficit | (121,656) | (91,219) |
| Total Stockholders' Equity | 14,478 | 24,937 |
| Total Liabilities and Stockholders' Equity | $20,944 | $33,709 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.